| Fahrmann, Johannes F |
University Of Tx Md Anderson Can Ctr
United States |
Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer |
5U01CA282216-03 |
|
Claire Zhu, Ph.D. |
| Zhou, Xianghong Jasmine |
University Of California Los Angeles
United States |
Multi-cancer early detection using cell-free DNA methylome analysis |
5U01CA285010-03 |
|
Nicholas Hodges, Ph.D. |
| Mcguire, Andrew |
Fred Hutchinson Cancer Center
United States |
Rational Vaccine Design to prevent HIV-Associated Lymphoma |
5R01CA285227-03 |
|
Anda Vlad, M.D., Ph.D. |
| Hansen, Laura A |
Creighton University
United States |
Targeting aberrant anti-apoptotic signaling for prevention of skin cancer |
5R01CA253573-05 |
|
Howard L. Parnes, M.D. |
| Ahn, Eun Hyun |
Johns Hopkins University
United States |
Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents |
5R01CA279948-02 |
|
Guillermo Marquez, Ph.D. |
| Borges, Chad R |
Arizona State University-Tempe Campus
United States |
Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions |
5R21CA269091-03 |
RFA-CA-21-005 (R21 Clinical Trial Not Allowed) |
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Simeone, Diane M |
University Of California, San Diego
United States |
Biomarker Validation in Pancreatic Cystic Neoplasms |
5U01CA282272-03 |
PAR-21-334 (U01 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Kumar, Nagi B. |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Phase II Clinical trial of GTC in Men on Active Surveillance |
5R01CA235032-06 |
|
Howard L. Parnes, M.D. |
| Kelleher, Sarah |
Duke University
United States |
Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients |
5R01CA291888-02 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Leal, Ana Sofia Mendes |
Indiana University Indianapolis
United States |
Nrf2, immune cells and lung cancer |
7R01CA226690-06 |
|
Marjorie Perloff, M.D. |
